Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a high base, while revenue from operations rose a modest 2.3% to Rs 7,119 crore. The company's EBITDA also declined, with margins contracting sharply compared with the year-ago quarter.
Cipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a high base, while revenue from operations rose a modest 2.3% to Rs 7,119 crore. The company's EBITDA also declined, with margins contracting sharply compared with the year-ago quarter.
<iframe src="https://hindustansphere.com/embed/cluster/839a151506abac54f8609dfc32a07e0e231d5632" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginally"></iframe>
